Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 275 Carcinoma, Intraductal, Noninfiltrating 25 Breast Carcinoma In Situ 21 Neoplasm Metastasis 14 Neoplasms 13 Breast Neoplasms, Male 12 Ovarian Neoplasms 10 Inflammatory Breast Neoplasms 7 Glioblastoma 6 Endometrial Neoplasms 6 Prostatic Neoplasms 5 Central Nervous System Neoplasms 5 Gliosarcoma 4 Fallopian Tube Neoplasms 4 Breast Cancer Female 4 Brain Neoplasms 4 Recurrence 3 Obesity 3 Hot Flashes 3 Glioma 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Ductal, Breast 3 Breast Diseases 3 Astrocytoma 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Sleep Wake Disorders 2 Sarcoma 2 Pancreatic Neoplasms 2 Oligodendroglioma 2

Interventions

trametinib 1 talimogene laherparepvec 1 spartalizumab 1 pembrolizumab 1 nazartinib 1 exemestane 1 canakinumab 1 Therapeutics 1 Telomerase 1 Tamoxifen 1 Surgical Procedures, Operative 1 Specimen Handling 1 Sentinel Lymph Node Biopsy 1 Radiation, Ionizing 1 Pemetrexed 1 Paclitaxel 1 Mastectomy, Subcutaneous 1 Mastectomy, Segmental 1 Mammaplasty 1 Letrozole 1 Indocyanine Green 1 Doxorubicin 1 Docetaxel 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Ductal × Tamoxifen × Clear all

NCT07499999 2026-03-30

BabyTEARS

Dana-Farber Cancer Institute

Phase 2 Not yet recruiting

Breast Neoplasms, Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡